Work

Deciphering immune-genomic markers of hyperprogression in patients (Pts) with metastatic urothelial cancer (mUC) treated with immune checkpoint inhibitors (ICIs).

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.840

Authors: Nikhil Pramod, Paul G. Pavicic, Scott Dawsey, Ubenthira Patgunarajah, Kimberly Maroli, Riya Malhotra, Moshe C. Ornstein, Timothy D. Gilligan, Christopher Eing Wee, Omar Y. Mian, Amanda Nizam, Ying Ni, Jane Nguyen, C. Marcela Diaz-Montero, Shilpa Gupta

Institutions: Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, John D. Dingell VA Medical Center, Fred Hutch Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407702684

Cites:

Cited by:

Related to: 10